A paper published by Nanjing First Hospital was withdrawn earlier this year because of the apparent duplication of images

2022-05-25 0 By

01 Paper Information December 2020,Nanjing First Hospital is located at Artificial Cells, NanomedicineAnd Biotechnology (IF 5.678/Q1) is online titled “Long non-coding RNA 91H regulates IGF2 expression by interacting with IGF2BP2And Promotes Tumorigenesis in colorectal cancer.Authors: First author: Tianyi Gao, Nanjing First Hospital;Corresponding author: Shukui Wang, Nanjing First Hospital.The results of the cell scratch experiment in Figure 1A are repeated.Bangshun He, one of the authors of the paper, replied: “Thank you very much for your comments on our study.We take your enquiry seriously.We are investigating and verifying the original records and raw data.We will assess the impact of these issues on the publication conclusions you list and contact the editorial department to correct errors if necessary.We appreciate your comments about our work and will respond as soon as possible.”On February 3, 2022, the journal retracted the article.The retraction statement reads: “Since the publication of the paper, the author has noticed a repetition in Figures 1A and 4A.Since this error directly affects the results and conclusions of the report, the author informs the editor and publisher of the problem and requests correction.The authors admitted that they had made mistakes, and the editors and publishers found fundamental flaws in the required corrections and in the rest of the paper.The author has agreed to retract the article.”Reference Information:https://pubpeer.com/publications/BAE98ED960B5BBAC656BA7DB5F3C3Dhttps://www.tandfonline.com/doi/full/10.1080/21691401.202Source: Retraction Express Authorized: Tencent Technology